AcquisitionUnder the terms of the acquisition, Bedrocan Canada shareholders will be entitled to receive 0.4650 common shares of TMI for each common share of Bedrocan Canada held. It is expected that TMI will issue a total of approximately 33.9 million common shares in connection with the acquisition having an aggregate value of approximately $61.0 million based on the $1.80 per share closing price of the TMI shares on the TSX Venture Exchange on June 23, 2015.
Read more at https://www.stockhouse.com/news/press-releases/2015/06/24/tweed-to-acquire-bedrocan-canada#gPUUF8Ov7It5TbwZ.99